Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wuzi Yanzong Pill is a traditional Chinese medicine (TCM) formula with a history of over a thousand years. It is primarily used for the treatment of male infertility and reproductive disorders. The formula consists of five herbal seeds—Lycii Fructus (Chinese wolfberry), Cuscutae Semen (dodder seed), Rubi Fructus (raspberry), Schisandrae Chinensis Fructus (Schisandra berry), and Plantaginis Semen (plantain seed). In TCM theory, it acts by tonifying the kidney and nourishing "Jing" or reproductive essence. Modern pharmacological studies suggest that its mechanisms may involve modulation of apoptosis pathways relevant to spermatogenesis via targets such as TP53, TNF, AKT1, Bcl-XL, BCL-2, and IκBA[6]. It has been shown in clinical studies to improve sperm parameters including motility and concentration in men with oligoasthenozoospermia[5][7]. The pill is also used for symptoms associated with kidney deficiency such as backache and premature ejaculation[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wuzi Yanzong Pill.